Sign in
4

Changes in Ownership

BioXcel Therapeutics, Inc. Filed Acc 0001104659-23-033403

CEO and President acquired 10,437 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mehta Vimal CEO and President 2023-03-14 Option exercise +10,437 20,394 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Mehta Vimal CEO and President 2023-03-14 Option exercise · Restricted Stock Units −10,437 31,313 D: show line 2 in the form
Mehta Vimal CEO and President 2023-03-15 Grant or award · Restricted Stock Units +56,000 56,000 D: show line 3 in the form
Mehta Vimal CEO and President 2023-03-15 Grant or award · Stock Option (Right to Buy) +168,000 168,000 D: show line 4 in the form
Loading xslF345X03/tm239796-4_4seq1.xml…